Jeffrey Henry LLP advise SkinBioTherapeutics on its £10.7 million AIM IPO

Jeffreys Henry LLP, the cost-effective Auditor to LSE and AIM listed companies, has recently advised SkinBioTherapeutics Plc ("The Company") on its £10.7 million AIM IPO.

SkinBioTherapeutics Plc is a life science company formed as a spin-out from the University of Manchester. The Company’s proprietary platform technology, SkinBiotix®, applies research discoveries made on the activities of lysates derived from probiotic bacteria when applied to skin. The Company has shown that the SkinBiotix® platform can improve the barrier effect of skin models, improve repair and reduce bacterial load. 

The IPO raised £4.5 million which will fund a whole host of work, including scale-up and manufacturing, formulation and testing in human volunteers.                                                   

Jeffreys Henry LLP acted as the Reporting Accountant in respect of the AIM IPO.

Ranked 12th place in the latest (May 2017) league table of Total AIM and Stock Market client, a team dedicated to working with listed companies and access to a global network, Jeffreys Henry LLP is a cost-effective Auditor for companies already listed, or considering listing, on the LSE, AIM, GEM, NEX or CSE markets.

For further information, or to review your AIM Audit cost, please contact:-

Nick Michaels

+44 (0) 207 309 2255
Client Relationship Partner 

After qualifying in 1982 as a Chartered Accountant, Nick worked at Arthur Andersen and then Ernst & Young before joining Jeffreys Henry LLP as a partner in 1986. Nick works exclusively with capital market clients, including LSE, AIM, NEX, GEM and CSE listed companies during a time of accelerated growth, reverse takeovers and mergers and acquisitions. He has an extensive contact network, and is highly regarded amongst Nomads, lawyers and brokers. Nick is also Director of Alfred Henry Corporate Finance Limited.

Sanjay Parmar

+44 (0) 207 309 2350
Audit Partner

Sanjay qualified as a Chartered Accountant in 1990. He is a corporate specialist with a client base in various sectors. Sanjay audits a number of LSE, AIM, NEX, GEM and CSE listed companies and has acted as the Reporting Accountant on a number of IPOs and reverse acquisitions. Sanjay has extensive experience in the application of International Financial Reporting Standards ("IFRS") and undertaking investigating accountant assignments on acquisitions.